Ideaya Biosciences Inc (NASDAQ: IDYA) on Monday, soared 5.81% from the previous trading day, before settling in for the closing price of $33.55. Within the past 52 weeks, IDYA’s price has moved between $13.45 and $37.08.
Annual sales at Healthcare sector company slipped by -0.01% over the past five years. The company achieved an average annual earnings per share of 61.78%. With a float of $83.79 million, this company’s outstanding shares have now reached $87.67 million.
Ideaya Biosciences Inc (IDYA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ideaya Biosciences Inc is 4.42%, while institutional ownership is 104.59%.
Ideaya Biosciences Inc (IDYA) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.49 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.62) by -0.87. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 61.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.61% during the next five years compared to -0.01% drop over the previous five years of trading.
Ideaya Biosciences Inc (NASDAQ: IDYA) Trading Performance Indicators
Ideaya Biosciences Inc (IDYA) is currently performing well based on its current performance indicators. A quick ratio of 12.44 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.86, a number that is poised to hit -0.93 in the next quarter and is forecasted to reach -3.52 in one year’s time.
Technical Analysis of Ideaya Biosciences Inc (IDYA)
Ideaya Biosciences Inc (NASDAQ: IDYA) saw its 5-day average volume 1.26 million, a positive change from its year-to-date volume of 1.15 million. As of the previous 9 days, the stock’s Stochastic %D was 37.26%.
During the past 100 days, Ideaya Biosciences Inc’s (IDYA) raw stochastic average was set at 89.46%, which indicates a significant increase from 60.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.46 in the past 14 days, which was higher than the 1.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.28, while its 200-day Moving Average is $24.29. Nevertheless, the first resistance level for the watch stands at $36.32 in the near term. At $37.14, the stock is likely to face the second major resistance level. The third major resistance level sits at $38.50. If the price goes on to break the first support level at $34.14, it is likely to go to the next support level at $32.78. Assuming the price breaks the second support level, the third support level stands at $31.96.
Ideaya Biosciences Inc (NASDAQ: IDYA) Key Stats
Market capitalization of the company is 3.11 billion based on 87,666K outstanding shares. Right now, sales total 7,000 K and income totals -274,480 K. The company made 207,830 K in profit during its latest quarter, and 119,240 K in sales during its previous quarter.
